These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3172130

  • 21. Orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
    Summers JB, Gunn BP, Martin JG, Mazdiyasni H, Stewart AO, Young PR, Goetze AM, Bouska JB, Dyer RD, Brooks DW.
    J Med Chem; 1988 Jan; 31(1):3-5. PubMed ID: 3336029
    [No Abstract] [Full Text] [Related]

  • 22. [Soy lipoxygenase as the object for the primary testing of potential inhibitors of leukotriene biosynthesis].
    Lototskaia LS, Naĭdenova IIu, Il'iasheva LM, Poda GI, Kornilov AI.
    Farmakol Toksikol; 1989 Jan; 52(2):59-62. PubMed ID: 2501105
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of leukotriene biosynthesis.
    Ford-Hutchinson AW.
    Ann N Y Acad Sci; 1991 Jan; 629():133-42. PubMed ID: 1952545
    [No Abstract] [Full Text] [Related]

  • 24. N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure.
    Musser JH, Kreft AF, Bender RH, Kubrak DM, Grimes D, Carlson RP, Hand JM, Chang J.
    J Med Chem; 1990 Jan; 33(1):240-5. PubMed ID: 2104935
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.
    Garscha U, Voelker S, Pace S, Gerstmeier J, Emini B, Liening S, Rossi A, Weinigel C, Rummler S, Schubert US, Scriba GK, Çelikoğlu E, Çalışkan B, Banoglu E, Sautebin L, Werz O.
    Biochem Pharmacol; 2016 Nov 01; 119():17-26. PubMed ID: 27592027
    [Abstract] [Full Text] [Related]

  • 27. 1,2-Cyclomethylenecarboxylic monoamide hydroxamic derivatives. A novel class of non-amino acid angiotensin converting enzyme inhibitors.
    Turbanti L, Cerbai G, Di Bugno C, Giorgi R, Garzelli G, Criscuoli M, Renzetti AR, Subissi A, Bramanti G, DePriest SA.
    J Med Chem; 1993 Mar 19; 36(6):699-707. PubMed ID: 8459398
    [Abstract] [Full Text] [Related]

  • 28. 2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesis.
    Hammond ML, Kopka IE, Zambias RA, Caldwell CG, Boger J, Baker F, Bach T, Luell S, MacIntyre DE.
    J Med Chem; 1989 May 19; 32(5):1006-20. PubMed ID: 2709371
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.
    Prasit P, Belley M, Blouin M, Brideau C, Chan C, Charleson S, Evans JF, Frenette R, Gauthier JY, Guay J.
    J Lipid Mediat; 1993 May 19; 6(1-3):239-44. PubMed ID: 8357985
    [Abstract] [Full Text] [Related]

  • 31. Synthesis, chemical, and biological properties of vinylogous hydroxamic acids: dual inhibitors of 5-lipoxygenase and IL-1 biosynthesis.
    Wright SW, Harris RR, Kerr JS, Green AM, Pinto DJ, Bruin EM, Collins RJ, Dorow RL, Mantegna LR, Sherk SR.
    J Med Chem; 1992 Oct 30; 35(22):4061-8. PubMed ID: 1433212
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. 5-Lipoxygenase.
    Ford-Hutchinson AW, Gresser M, Young RN.
    Annu Rev Biochem; 1994 Oct 30; 63():383-417. PubMed ID: 7979243
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4 synthase.
    Gupta N, Nicholson DW, Ford-Hutchinson AW.
    Can J Physiol Pharmacol; 1997 Oct 30; 75(10-11):1212-9. PubMed ID: 9431445
    [Abstract] [Full Text] [Related]

  • 36. Quantitative structure-activity relationship study on some 5-lipoxygenase inhibitors.
    Gupta SP, Gupta JK.
    J Enzyme Inhib; 1990 Oct 30; 3(3):179-88. PubMed ID: 2079634
    [Abstract] [Full Text] [Related]

  • 37. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on bronchial anaphylaxis in anaesthetized guinea-pigs.
    Payne AN, Garland LG, Lees IW, Salmon JA.
    Br J Pharmacol; 1988 Jun 30; 94(2):540-6. PubMed ID: 3395791
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Suppression of 5-lipoxygenase activity by anionic cholesterol derivatives].
    Aleksandov DA, Sud'ina GF.
    Biomed Khim; 2006 Jun 30; 52(5):511-7. PubMed ID: 17180926
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.